関連する実験動画
Updated: Jul 13, 2026

11:06
Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
Published on: April 23, 2019
エキノカンジンの抗真菌薬は,
1Education and Research Centre, Wythenshawe Hospital, Southmoor Road, M23 9LT, Manchester, UK. ddenning@man.ac.uk
Lancet (London, England)
|October 11, 2003
まとめ
エキノカンジンは,真菌細胞壁の合成を阻害する抗真菌薬です. 伝統的な抗真菌薬と比較して副作用が少ない効果的な治療法として有望であることが示されています.
科学分野:
- 薬理学 薬理学とは
- 菌類学 菌類学とは
背景:
- エキノカンジンは,ベータ-1,3-グルカンの合成を標的としたリポペプチド抗真菌剤です.
- このメカニズムは,真菌の細胞壁を損傷させ,真菌殺菌または真菌滅菌効果をもたらします.
研究 の 目的:
- エキノカンジンの性質と臨床応用について検討する.
- 既存の抗真菌療法との効果と安全性を比較する.
主な方法:
- in vitroおよびin vivoの研究に関する文献レビュー.
- カスポフンジンとミカフンギンの臨床試験データの分析.
- 薬理動力学および薬理動力学的性質の評価.
主要な成果:
- エキノカンジンは,Candida spp. に対して有効です. そして,アスペルギルス spp. しかし,Zygomycetes,Cryptococcus neoformans,またはFusarium spp.は含まれていない.
- カスポフンジンは,耐火性侵襲性アスペルギロシスにおける40%の応答率を示した.
- 研究によると,エキノカンジンは安全性プロファイルが向上したアンフォテリシンBと同等の有効性を有していることが示唆されています.
結論:
- エキノカンジンは,好ましい安全性プロファイルを提供し,静脈内投与に適しています.
- 限られた薬物相互作用と1日1回投与は,それらの臨床的有用性を高めます.
- 他の抗真菌薬,特に侵入性アスペルギロシスの併用療法の可能性.
関連する概念動画
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

